| |
Latest 10 SEC filings (by transaction date) for APT within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 25/24 | Mar 21/24 | Mcdonald Colleen J | Direct Ownership | common stock | S - Open market or private sale | -10,000 | $6.20 |
Mar 25/24 | Mar 21/24 | Mcdonald Colleen J | Direct Ownership | common stock | S - Open market or private sale | -10,000 | $6.11 |
Mar 22/24 | Mar 21/24 | Ritota John | Direct Ownership | options | M - Exercise or conversion exempt under rule 16b-3 | -5,000 | |
Mar 22/24 | Mar 21/24 | Ritota John | Direct Ownership | options | M - Exercise or conversion exempt under rule 16b-3 | -5,000 | |
Mar 22/24 | Mar 21/24 | Ritota John | Direct Ownership | options | M - Exercise or conversion exempt under rule 16b-3 | -5,000 | |
Mar 22/24 | Mar 21/24 | Ritota John | Direct Ownership | Common Stock | S - Open market or private sale | -819 | $5.94 |
Mar 22/24 | Mar 21/24 | Ritota John | Direct Ownership | options | M - Exercise or conversion exempt under rule 16b-3 | 15,000 | $3.42 |
Mar 22/24 | Mar 20/24 | Ritota John | Direct Ownership | Common Stock | S - Open market or private sale | -6,181 | $5.97 |
Mar 26/24 | Mar 18/24 | Hoffman Lloyd | Direct Ownership | options | M - Exercise or conversion exempt under rule 16b-3 | -33,333 | |
Mar 26/24 | Mar 18/24 | Hoffman Lloyd | Direct Ownership | options | M - Exercise or conversion exempt under rule 16b-3 | -33,333 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for APT within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 26/24 | Mar 15/24 | Buchan James | Direct Ownership | Options | M - Exercise or conversion exempt under rule 16b-3 | -5,000 | |
Mar 26/24 | Mar 15/24 | Buchan James | Direct Ownership | Options | M - Exercise or conversion exempt under rule 16b-3 | -5,000 | |
Mar 26/24 | Mar 15/24 | Buchan James | Direct Ownership | Options | M - Exercise or conversion exempt under rule 16b-3 | -5,000 | |
Mar 26/24 | Mar 15/24 | Buchan James | Direct Ownership | Common Stock | S - Open market or private sale | -1,000 | $5.78 |
Mar 26/24 | Mar 15/24 | Buchan James | Direct Ownership | Common Stock | S - Open market or private sale | -14,000 | $5.82 |
Mar 26/24 | Mar 15/24 | Buchan James | Direct Ownership | options | M - Exercise or conversion exempt under rule 16b-3 | 15,000 | $3.42 |
Mar 26/24 | Mar 18/24 | Hoffman Lloyd | Direct Ownership | options | M - Exercise or conversion exempt under rule 16b-3 | -33,333 | |
Mar 26/24 | Mar 18/24 | Hoffman Lloyd | Direct Ownership | options | M - Exercise or conversion exempt under rule 16b-3 | -33,333 | |
Mar 26/24 | Mar 18/24 | Hoffman Lloyd | Direct Ownership | options | M - Exercise or conversion exempt under rule 16b-3 | -33,334 | |
Mar 26/24 | Mar 18/24 | Hoffman Lloyd | Direct Ownership | Common stock | M - Exercise or conversion exempt under rule 16b-3 | 100,000 | $3.62 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Cencora (N:COR) |
DexCom (OQ:DXCM) |
West Pharmaceutical Servi (N:WST) |